Cytosurge wins Bruker as partner


Cytosurge, the provider of high-precision nanotechnology instruments has won Bruker, one of the world's leading analytical instrumentation companies with over 6000 employees worldwide, as its partner. Bruker will launch cytosurge’s FluidFM on its BioScope Resolve AFM, bringing a whole range of novel single-cell investigations.


Cytosurge AG, a Zurich based company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM technology. Its newly acquired partner, Bruker Corporation, is one of the world's leading analytical instrumentation companies developing high-performance scientific instruments and high-value analytical and diagnostic solutions to enable scientists to explore life and materials at molecular, cellular and microscopic levels.

Through their partnership, Bruker will launch FluidFM on its BioScope Resolve AFM making it even more powerful. The PeakForce QNM and FastForce Volume capabilities of the BioScope Resolve combined with FluidFM technology open a broad range of FluidFM applications for BioScope Resolve BioAFM users – from single cell adhesion and injection into single cells, through colloidal studies to nanolithography.

“Partnering with Cytosurge to integrate FluidFM with BioScope Resolve and PeakForce Tapping technology fits perfectly with our strategy to take BioAFM experiments beyond imaging, from mechanobiology and drug delivery to the probing of biochemical interactions. Manipulating cells, and injecting biomolecules into cells while sensing piconewton forces, and imaging at the nanometer scale, are AFM capabilities that enable fundamentally new correlative information”, said David V. Rossi, Executive Vice President and General Manager of Bruker's AFM Business.

“Working together with Bruker as one of the world’s leading AFM providers marks an important milestone for Cytosurge. This new Premium partnership reinforces our vision of enabling the full potential of FluidFM technology to the benefit the researchers worldwide”, said Pascal Behr, CEO of Cytosurge AG.

The Partnership with Bruker is the third of a series between Cytosurge and leading AFM manufacturers, after the partnership with Nanosurf, a Swiss-based high-tech company providing scanning probe microscopes including atomic force microscope systems, and JPK Instruments, the manufacturer of nanoanalytic instruments, particularly atomic force microscopes (AFM) systems and optical tweezers.

(Press release)